MedPath

Aripiprazole Used as Dual Therapy in the Treatement of Patients With Chronic Stable Schizophrenia or Schizoaffective Disorder.

Phase 4
Completed
Conditions
Schizophrenia
Schizoaffective Disorder
Interventions
Registration Number
NCT00325689
Lead Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Brief Summary

A Multicenter, Double-blind 16 Week Study on the augmentation of atypical antipsychotic with Aripiprazole in patients with Schizophrenia with inadequate response to antipsychotic treatment.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
323
Inclusion Criteria
  • Patient with diagnosis of chronic Schizophrenia or Schizoaffective disorder
  • Stable symptoms and dose of Quetiapine or Risperidone
Exclusion Criteria
  • First diagnosis in the past year
  • Significant risk of suicide or meet DSM-IV-TR criteria for substance abuse

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Quetiapine or Risperidone + AripiprazoleQuetiapine or Risperidone + Aripiprazole-
Quetiapine or Risperidone + placeboQuetiapine or Risperidone + placebo-
Primary Outcome Measures
NameTimeMethod
Evaluate the efficacy of adding Aripiprazole to atypical antipsychotic treatment via Positive and Negative Symptoms Scale (PANSS) score at endpoint(Week 16) or at time of discontinuation
Secondary Outcome Measures
NameTimeMethod
Assess efficacy according to changes in the severity of illness symptoms as measured by the Clinical Global Impressions-Severity (CGI-S)at endpoint (Week 16)

Trial Locations

Locations (47)

Atp Clinical Research, Inc.

🇺🇸

Costa Mesa, California, United States

J. Gary Booker, Md

🇺🇸

Shreveport, Louisiana, United States

Sheppard Pratt Health System

🇺🇸

Baltimore, Maryland, United States

North Suffolk Mental Health Association

🇺🇸

Boston, Massachusetts, United States

Cri Worldwide, Llc

🇺🇸

Philadelphia, Pennsylvania, United States

Belmont Center For Comprehensive Treatment

🇺🇸

Philadelphia, Pennsylvania, United States

Medlabs Research Of Houston, Inc.

🇺🇸

Houston, Texas, United States

University Of Minnesota

🇺🇸

Minneapolis, Minnesota, United States

Indiana University School Of Medicine

🇺🇸

Indianapolis, Indiana, United States

Lsu Health Sciences Center

🇺🇸

Shreveport, Louisiana, United States

Community Counseling Of Bristol County, Inc. (Ccbc)

🇺🇸

Taunton, Massachusetts, United States

Institute Of Living

🇺🇸

Hartford, Connecticut, United States

San Fernando Mental Health Center

🇺🇸

Granada Hills, California, United States

Behavioral Medical Research Of Staten Island

🇺🇸

Staten Island, New York, United States

Richmond Behavioral Associates

🇺🇸

Staten Island, New York, United States

Va Medical Center (116a)

🇺🇸

Philadelphia, Pennsylvania, United States

Schuster Medical Research Institute

🇺🇸

Sherman Oaks, California, United States

Saroj B. Brar, M.D., Inc.

🇺🇸

Cleveland, Ohio, United States

New York State Psychiatric Institute

🇺🇸

New York, New York, United States

Manhattan Psychiatric Center

🇺🇸

New York, New York, United States

Midwest Clinical Research Center

🇺🇸

Dayton, Ohio, United States

Department Of Veterans Affairs Medical Center

🇺🇸

Coatesville, Pennsylvania, United States

Suburban Research Associates

🇺🇸

Media, Pennsylvania, United States

University Of Texas Health Science Center At San Antonio

🇺🇸

San Antonio, Texas, United States

Va Puget Sound Health Care System

🇺🇸

Tacoma, Washington, United States

K & S Professional Research Services, Llc

🇺🇸

Little Rock, Arkansas, United States

Comprehensive Neuroscience, Inc.

🇺🇸

Cerritos, California, United States

California Clinical Trials Medical Group

🇺🇸

Paramount, California, United States

Collaborative Neuroscience Network, Inc.

🇺🇸

Garden Grove, California, United States

Uci Medical Center

🇺🇸

Orange, California, United States

California Clinical Trials

🇺🇸

San Diego, California, United States

Sharp Mesa Vista Hospital

🇺🇸

San Diego, California, United States

California Neuropsychopharmacology Clinical Research Inst.

🇺🇸

San Diego, California, United States

University Of Colorado At Denver And Health Sciences Center

🇺🇸

Denver, Colorado, United States

Department Of Psychiatry And Behavioral Sciences

🇺🇸

Stanford, California, United States

Pacific Clinical Research Medical Group

🇺🇸

Upland, California, United States

Uptown Research Institute, Llc

🇺🇸

Chicago, Illinois, United States

Behavioral Clinical Research, Inc

🇺🇸

North Miami, Florida, United States

Alexian Center For Psychiatric Research

🇺🇸

Hoffman Estates, Illinois, United States

Precise Research Centers

🇺🇸

Flowood, Mississippi, United States

Advanced Bio-Behavioral Sciences

🇺🇸

Elmsford, New York, United States

Neurobehavioral Research, Inc.

🇺🇸

Cedarhurst, New York, United States

The Zucker Hillside Hospital

🇺🇸

Glen Oaks, New York, United States

Strong Ties Community Support Program

🇺🇸

Rochester, New York, United States

Duke University Health System

🇺🇸

Durham, North Carolina, United States

Vanderbilt University Medical Center

🇺🇸

Nashville, Tennessee, United States

Thomas Jefferson University

🇺🇸

Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath